Related Experiment Video
Updated: Jul 19, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac
Patricia Rodriguez1, Bryan Mitton, Jason R Waggoner
1Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267, USA.
Abstract:
Human and experimental heart failure is characterized by increases in type-1 protein phosphatase activity, which may be partially attributed to inactivation of its endogenous regulator, protein phosphatase inhibitor-1. Inhibitor-1 represents a nodal integrator of two major second messenger pathways, adenosine 3',5'-cyclic monophosphate (cAMP) and calcium, which mediate its phosphorylation at threonine 35 and serine 67, respectively. Here, using recombinant inhibitor-1 wild-type and mutated proteins, we identified a novel phosphorylation site in inhibitor-1, threonine 75. This phosphoamino acid was phosphorylated in vitro by protein kinase Calpha independently and to the same extent as serine 67, the previous protein kinase Calpha-identified site. Generation of specific antibodies for the phosphorylated and dephosphorylated threonine 75 revealed that this site is phosphorylated in rat and dog hearts. Adenoviral-mediated expression of the constitutively phosphorylated threonine 75 inhibitor-1 in isolated myocytes was associated with specific stimulation of type-1 protein phosphatase activity and marked inhibition of the sarcoplasmic calcium pump affinity for calcium, resulting in depressed contractility. Thus, phosphorylation of inhibitor-1 at threonine 75 represents a new mechanism of cardiac contractility regulation, partially through the alteration of sarcoplasmic reticulum calcium transport activity.
Insights
A new phosphorylation site on protein phosphatase inhibitor-1 (threonine 75) was discovered. This finding reveals a novel mechanism regulating cardiac contractility and heart failure progression.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Protein Phosphorylation
Background:
- Heart failure is linked to increased type-1 protein phosphatase activity.
- Protein phosphatase inhibitor-1 regulates this activity and integrates cAMP and calcium signaling.
- Known phosphorylation sites on inhibitor-1 include threonine 35 and serine 67.
Purpose of the Study:
- To identify novel regulatory mechanisms of protein phosphatase inhibitor-1.
- To investigate the role of inhibitor-1 phosphorylation in cardiac function.
Main Methods:
- Utilized recombinant wild-type and mutated inhibitor-1 proteins.
- Generated specific antibodies for phosphorylated threonine 75.
- Employed adenoviral-mediated gene transfer in isolated myocytes.
Main Results:
- Identified threonine 75 as a novel phosphorylation site on inhibitor-1, phosphorylated by protein kinase Calpha.
- Confirmed threonine 75 phosphorylation in rat and dog hearts.
- Constitutive phosphorylation of threonine 75 in myocytes stimulated type-1 protein phosphatase activity and impaired calcium pump function, reducing contractility.
Conclusions:
- Phosphorylation of inhibitor-1 at threonine 75 is a newly identified mechanism in cardiac contractility regulation.
- This phosphorylation impacts sarcoplasmic reticulum calcium transport.
- Alterations in inhibitor-1 phosphorylation may contribute to the pathophysiology of heart failure.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
The JAK-STAT Signaling Pathway
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
PI3K/mTOR/AKT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

